Skip to main content
Clinical Trials/NCT00436982
NCT00436982CompletedNot Applicable

Evaluation of Triathlon - a New Total Knee Prosthesis System. Prospective, Comparative, Randomised, Roentgen Stereophotogrammetric Analysis (RSA) Series

Stryker Orthopaedics1 site in 1 country60 target enrollmentStarted: February 1, 2006Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Roentgen Stereophotogrammetric Analysis (RSA)

Study Overview

Brief Summary

The objective is to investigate the Clinical, Radiographic, Roentgen Stereophotogrammetric behaviour and patient outcome when using the Triathlon total knee prosthesis in a prospective randomized clinical trial.

Detailed Description

The evaluation is carried out by a prospective randomised RSA-study with Triathlon cemented knee prosthesis versus Duracon cemented knee prosthesis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients suffering exclusively from osteo arthritis (OA), Stage II-V [Ahlbäck, 1968] will be operated.
  • •Patients requiring knee prosthesis, suitable for the use of Duracon and Triathlon knee system
  • •Patients who understand the conditions of the study and are willing and able to comply with the post-operative scheduled clinical and radiographical evaluations and the prescribed rehabilitation.
  • •Patients who signed the Ethics Committee approved Informed Consent Form prior to surgery.

Exclusion Criteria

  • •Previous major knee surgery
  • •Other significant disabling problems from the muscular-skeletal system than in the knees
  • •Obese patients where obesity is severe enough to affect subject's ability to perform activities of daily living (body mass index, kg/m2: BMI above 35).
  • •Patients with active or suspected infection.
  • •Patients with malignancy - active malignancy.
  • •Patients with severe osteoporosis, Paget's disease, renal osteodystrophy.
  • •Patients immunologically suppressed, or receiving steroids in excess of physiologic dose requirements.
  • •The patient has a neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device or the patient has a neurological deficit which interferes with the patient's ability to limit weight bearing or places an extreme load on the implant during the healing period.
  • •Female patients planning a pregnancy during the course of the study.
  • •Patients with systemic or metabolic disorders leading to progressive bone deterioration.
  • •Patients, who as judged by the surgeon, are mentally incompetent or are unlikely to be compliant with the prescribed post-operative routine and follow-up evaluation schedule.
  • •Patients with other severe concurrent joint involvements, which can affect their outcome.
  • •Patients with other concurrent illnesses, which are likely to affect their outcome such as sickle cell anaemia, systemic lupus erythematosus or renal disease requiring dialysis.
  • •Patients under the protection of law (e.g. guardianship).

Arms & Interventions

Cemented Triathlon total knee system

Active Comparator

The Triathlon total knee system is the successor of the Duracon total knee system and was observed in a prospective randomised, parallel, double-blind study.

Intervention: Cemented Triathlon total knee system (Device)

Cemented Duracon total knee system

Active Comparator

The Duracon total knee system is the predecessor of the Triathlon total knee system and was observed in a prospective randomised, parallel, double-blind study.

Intervention: Duracon total knee system (Device)

Outcomes

Primary Outcomes

Roentgen Stereophotogrammetric Analysis (RSA)

Time Frame: 2 years

To compare the maximum total point motion (MTPM) of the Triathlon and Duracon tibial components at two years assessed by means of RSA.

Secondary Outcomes

  • Duration Hospital Stay(preoperative to discharge)
  • Mean Operative Time(intra-operative)
  • Blood Loss(intra-operative)
  • Roentgen Stereophotogrammetric Analysis (RSA)(3 months, 1, 5, 7 and 10 years)
  • Investigation of Clinical Performance and Patient Outcome With KSS (Knee Society Score)([Time Frame: pre-operative, 3 months, 1, 2, 5, 7 and 10 years])
  • Investigation of Clinical Performance and Patient Outcome With EQ-5D Patient Questionnaire(pre-operative, 3 months, 1, 2, 5, 7 and 10 years)
  • Investigation of Clinical Performance and Patient Outcome With KOOS Patient Questionnaire(pre-operative, 3 months, 1, 2, 5, 7 and 10 years)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials